BREAST CANCER RECURRENT
Clinical trials for BREAST CANCER RECURRENT explained in plain language.
Never miss a new study
Get alerted when new BREAST CANCER RECURRENT trials appear
Sign up with your email to follow new studies for BREAST CANCER RECURRENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
One-Week radiation blasts recurrent breast cancer, spares healthy tissue
Disease control Recruiting nowThis study tests whether a 1-week course of partial breast radiation is safe and effective for women who have had a breast cancer recurrence after prior whole-breast radiation. Participants will receive targeted radiation after breast-conserving surgery to remove the new tumor. T…
Matched conditions: BREAST CANCER RECURRENT
Phase: NA • Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated Jun 27, 2026 12:39 UTC
-
New pill targets Hard-to-Treat cancers in early human trial
Disease control Recruiting nowThis study is testing an experimental oral drug called ATX-295 in people with advanced solid tumors, including ovarian cancer, that have not responded to standard treatments. The main goal is to find a safe and tolerable dose and to see if the drug can shrink tumors. About 90 par…
Matched conditions: BREAST CANCER RECURRENT
Phase: PHASE1 • Sponsor: Accent Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
Heat boost: new combo therapy aims to shrink incurable tumors
Symptom relief Recruiting nowThis study tests whether adding a special heat treatment (water-filtered infrared, or wIRA) to standard palliative radiation can help shrink tumors and ease symptoms in people with advanced head, neck, or skin cancer that cannot be cured. About 60 adults will receive the combined…
Matched conditions: BREAST CANCER RECURRENT
Phase: NA • Sponsor: King's College London • Aim: Symptom relief
Last updated Jun 27, 2026 08:05 UTC
-
Can Lab-Grown tumors stop breast cancer from coming back?
Knowledge-focused Recruiting nowThis study is testing a new approach called Functional Precision Oncology for people with triple-negative or HR-low/HER2- breast cancer at high risk of early recurrence. Researchers will create personalized tumor models (in mice and lab dishes) from each patient's cancer to find …
Matched conditions: BREAST CANCER RECURRENT
Phase: PHASE2 • Sponsor: University of Utah • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:07 UTC